nad has been researched along with Heart Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdellatif, M; Kroemer, G; Sedej, S | 1 |
| Chakraborty, A; Chiao, YA; Lee, CF; Minor, KE; Nizami, HL | 1 |
| Altara, R; Booz, GW; Mericskay, M; Muhieddine, DH; Refaat, MM; Tannous, C; Zouein, FA | 1 |
| Ahmed, MS; Attramadal, H; Aukrust, P; Bergersen, LH; Esbensen, QY; Halvorsen, B; Lauritzen, KH; Olsen, MB; Rinholm, JE; Sverkeli, LJ; Yang, K; Yndestad, A; Ziegler, M | 1 |
| Gou, B; He, C; Li, Y; Song, M; Wang, Y | 1 |
| Brockman, J; Cao, T; Fan, GC; Ni, R; Peng, T; Wang, G; Zhang, L; Zhang, Y; Zheng, D; Zheng, M; Zhong, H | 1 |
| Hershberger, KA; Hirschey, MD; Martin, AS | 1 |
| Chua, BH; Diotte, NM; Gao, J; Ho, YS; Xiong, Y | 1 |
| Aon, MA; Liu, T; O'Rourke, B; Zhou, L | 1 |
| Klaus, W; Rump, AF; Schierholz, J | 1 |
| ANFOSSI, A; GUARRAGGI, A | 1 |
| Crescimanno, M; Crosta, L; D'Alessandro, N; Dusonchet, L; Rausa, L | 1 |
| Güttler, K; Klaus, W; Rösen, R; Rump, AF; Schierholz, J | 1 |
| Nylen, EG; Wrogemann, K | 1 |
| Dessault, O; Donsez, D; Duboc, D; Guérin, F; Pocidalo, JJ; Polianski, J; Renault, G; Schved, M; Toussaint, M; Weber, S | 1 |
| Aoki, T | 1 |
| Iskushev, VS; Lifshits, RI; Slobodin, VB | 1 |
| Dube, V; Hunter, DT; Knight, JA | 1 |
| King, J; McQueen, MJ | 1 |
6 review(s) available for nad and Heart Diseases
| Article | Year |
|---|---|
Harnessing NAD
Topics: Heart Diseases; Heart Failure; Humans; NAD; Oxidation-Reduction | 2022 |
Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases.
Topics: Animals; Energy Metabolism; Epithelium; Heart Diseases; Humans; Mitochondria; Myocardium; NAD | 2021 |
Mitochondrial regulation of cardiac aging.
Topics: Aging; Animals; DNA, Mitochondrial; Heart; Heart Diseases; Humans; Mitochondria, Heart; Mitophagy; Mutation; Myocardium; NAD; Reactive Oxygen Species; Sirtuins; Unfolded Protein Response | 2019 |
Role of NAD
Topics: Animals; Disease Models, Animal; Heart; Heart Diseases; Humans; Kidney; Kidney Diseases; Mitochondria; NAD; Oxidation-Reduction; Signal Transduction; Sirtuins | 2017 |
[Lactate dehydrogenase (LDH) and its isoenzymes--how to read its figures].
Topics: Chemical Phenomena; Chemistry; Chemistry, Physical; Chromatography; Clinical Enzyme Tests; Diet; Electrophoresis; Heart Diseases; Hematologic Diseases; Humans; Immunoglobulin A; Isoenzymes; L-Lactate Dehydrogenase; Liver Diseases; Methods; NAD; Neoplasms | 1971 |
Synergism of cobalt and thanol.
Topics: Alcoholic Intoxication; Animals; Beer; Canada; Cobalt; Diet; Drug Synergism; Ethanol; Food Additives; Heart Diseases; Humans; NAD; Rats; United States | 1971 |
14 other study(ies) available for nad and Heart Diseases
| Article | Year |
|---|---|
NAD
Topics: Aging; Animals; Heart Diseases; Heart Failure; Humans; Hydrolases; Myocytes, Cardiac; NAD | 2021 |
Instability in NAD
Topics: Animals; DNA Damage; DNA Repair; DNA, Mitochondrial; Heart; Heart Diseases; HeLa Cells; Humans; Mice; Mitochondria; Myocardium; NAD; Niacinamide; Pyridinium Compounds; Sirtuins | 2021 |
Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
Topics: Animals; Antioxidants; Autophagy; Cardiotoxicity; Cells, Cultured; Cytoprotection; Disease Models, Animal; Doxorubicin; Heart Diseases; Hydrogen-Ion Concentration; Lysosomes; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; NAD; Niacinamide; Oxidative Stress; Pyridinium Compounds; Sirtuin 1 | 2019 |
Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2.
Topics: Animals; BH3 Interacting Domain Death Agonist Protein; Cell Respiration; Creatine Kinase; Cytochromes c; Cytoprotection; Doxorubicin; Flavin-Adenine Dinucleotide; Glutaredoxins; Glutathione; Heart Diseases; Humans; Mice; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Proteins; Myocardium; Myocytes, Cardiac; NAD; Ventricular Function, Left | 2009 |
Dynamic modulation of Ca2+ sparks by mitochondrial oscillations in isolated guinea pig cardiomyocytes under oxidative stress.
Topics: Animals; Benzodiazepinones; Calcium; Calcium Channels, L-Type; Free Radical Scavengers; GABA-A Receptor Antagonists; Glutathione; Guinea Pigs; Heart Diseases; Ion Channel Gating; Lasers; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondria, Heart; Myocytes, Cardiac; NAD; Oxidation-Reduction; Oxidative Stress; Photons; Porphyrins; Reactive Oxygen Species; Receptors, GABA-A; Ryanodine Receptor Calcium Release Channel; Ultraviolet Rays | 2011 |
Studies on the cardiotoxicity of noradrenaline in isolated rabbit hearts.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Circulation; Electric Stimulation; Heart; Heart Diseases; Heart Rate; In Vitro Techniques; Male; Microscopy, Fluorescence; Myocardial Ischemia; NAD; Norepinephrine; Perfusion; Pericardium; Rabbits; Ventricular Function, Left | 2002 |
[Experiences with a new cardioactive compound: Cardiozyme].
Topics: Coenzyme A; Cytochromes; Heart Diseases; Humans; Liver Extracts; Myocardium; NAD; Tissue Extracts | 1963 |
Does catalase play a role in Adriamycin induced cardiotoxicity?
Topics: Animals; Catalase; Doxorubicin; Female; Heart Diseases; Malondialdehyde; Mice; Myocardium; NAD | 1981 |
Studies on the role of superoxide anion radicals for the cardiotoxicity of adrenochrome.
Topics: Adrenochrome; Animals; Coronary Circulation; Epinephrine; Heart Diseases; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Microscopy, Fluorescence; NAD; Oxidation-Reduction; Oxygen Consumption; Pericardium; Rabbits; Superoxide Dismutase; Superoxides; Ventricular Function, Left | 2001 |
Mitochondrial calcium overloading in cardiomyopathic hamsters.
Topics: Animals; Calcium; Cell Fractionation; Cricetinae; Heart Diseases; Magnesium; Mitochondria, Heart; Mitochondria, Muscle; NAD; Oxidative Phosphorylation | 1978 |
[Study of myocardial metabolism of NADH by laser fluorimetry during cardiac catheterization].
Topics: Cardiac Catheterization; Female; Fiber Optic Technology; Fluorometry; Heart Diseases; Hemodynamics; Humans; Lasers; Male; Middle Aged; Myocardium; NAD | 1987 |
[The effect of L-aspartic acid in isoproterenol necrosis of cardiac muscle].
Topics: Alanine Transaminase; Amino Acids; Animals; Aspartate Aminotransferases; Aspartic Acid; Heart Diseases; Isoenzymes; Isoproterenol; L-Lactate Dehydrogenase; Liver; Malate Dehydrogenase; Mitochondria, Muscle; Myocardium; NAD; Necrosis; Oxidative Phosphorylation; Oxygen Consumption; Phosphates; Rabbits | 1972 |
Automated spectrophotometric assay of serum lactic dehydrogenase and hydroxybutyric dehydrogenase with clinical evaluation.
Topics: Automation; Heart Diseases; Humans; Hydroxybutyrate Dehydrogenase; Keto Acids; L-Lactate Dehydrogenase; Lung Diseases; Methods; Muscular Diseases; NAD; NADP; Pyruvates; Spectrophotometry | 1968 |
The reduction of hydroxypyruvate by human serum.
Topics: Butyrates; Electrophoresis; Glycerol; Heart Diseases; Humans; Hydrogen-Ion Concentration; Hydroxybutyrate Dehydrogenase; Isoenzymes; Keto Acids; L-Lactate Dehydrogenase; Lithium; NAD; NADP; Oxidation-Reduction; Pyruvates; Structure-Activity Relationship; Temperature | 1971 |